The Central Drug Standards Control Organization (CDSCO) has granted approval to Biolumpivaxin, India's first vaccine against lumpy skin disease (LSD) in dairy cattle and buffaloes. Developed by Biovet, a Bharat Biotech group company, this novel indigenous live-attenuated marker vaccine is set to revolutionize veterinary healthcare in India.